Creative Biolabs is dedicated to providing a full range of pseudouridine related services for our worldwide customers with years of RNA modification experience and high-end technologies.
As one of the modified nucleoside, pseudouridine (Ψ) was the first one to be discovered as well as the most abundant RNA modification in the body. Ψ, also known as 5-β-D-ribofuranosyluracil and so-called fifth nucleoside, is the 5-ribosyl isomer of nucleoside uridine, of which the uracil of the base is linked to ribose sugar by carbon-carbon (C-C) bond rather than nitrogen carbon (N-C) glycosyl bond. Compared with the usual N-C bond found in uridine, the C-C bond structure in Ψ has greater rotational freedom. Besides, the empty N-H can serve as an additional hydrogen bond donor to participate in pairing interaction or other functional activities. These structural and functional advantages have been gradually exploited for RNA development.
Fig.1 Chemical differences between Uridine and Pseudouridine.1
Fig.2 Distribution of Ψ and Ψ synthases in Homo sapiens.2
The properties and presence of Ψ suggest that Ψ or pseudouridylation exert significant roles in various physiological and biological activities, such as the stability of RNAs structure, ribosome diversity, translational control, even protein expression. Ψ abnormality also associates with some pathological conditions. Therefore, Ψ detection and activity analysis will provide useful information for biological stability improvement of RNA, revealing the relationship between the structure and function of modified RNA, and new therapeutic directions of some human diseases.
Creative Biolabs, a leading biotechnology company in bio-drug discovery, provides the most qualified pseudouridine modification services based on our well-established technical platform. Also, our seasoned scientists offer tailored solutions for effective epigenetic therapy development based on RNA modifications.
Inquire About Our ServicesA: Pseudouridine (Ψ) is a modified nucleoside known as the 5-ribosyl isomer of uridine, enhancing RNA stability and function.
A: It stabilizes RNA structures, improves translational accuracy, and enhances RNA's overall functionality
A: Pseudouridine is found in rRNA, tRNA, snRNA, mRNA, and microRNA.
A: Services include pseudouridine modification, epigenetic therapy development, and activity analysis.
A: Applications include studying RNA structure-function relationships and developing RNA-based therapies.
A: Verification is done through analytical methods such as mass spectrometry and NMR spectroscopy.
The article investigates the role of pseudouridine (Ψ) in RNA. It reveals that pseudouridine modifications occur during transcription in pre-mRNA, particularly in regions associated with alternative splicing. The study identifies three key pseudouridine synthases (PUS1, PUS7, and RPUSD4) that mediate these modifications, influencing alternative splicing and 3' end processing. By profiling chromatin-associated RNA, the research shows that pseudouridylation affects splicing efficiency and overlaps with RNA-binding protein sites, suggesting a regulatory role in pre-mRNA processing and gene expression.
Fig.3 Pseudouridines are enriched around splicing regulatory features and directly affect splicing.3
Cat. No | Product Name | Promoter |
---|---|---|
CAT#: GTVCR-WQ001MR | IVTScrip™ pT7-mRNA-EGFP Vector | T7 |
CAT#: GTVCR-WQ002MR | IVTScrip™ pT7-VEE-mRNA-EGFP Vector | T7 |
CAT#: GTVCR-WQ003MR | IVTScrip™ pT7-VEE-mRNA-FLuc Vector | T7 |
CAT#: GTVCR-WQ87MR | IVTScrip™ pT7-VEE-mRNA-Anti-SELP, 42-89-glycoprotein Vector | T7 |
Cat. No | Product Name | Type |
---|---|---|
CAT#: GTTS-WQ001MR) | IVTScrip™ mRNA-EGFP (Cap 1, 30 nt-poly(A)) | Reporter Gene |
CAT#: GTTS-WK18036MR | IVTScrip™ mRNA-Human AIMP2, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) | Enzyme mRNA |
(CAT#: GTTS-WQ004MR) | IVTScrip™ mRNA-Fluc (Cap 1, 30 nt-poly(A)) | Reporter Gene |
(CAT#: GTTS-WQ009MR) | IVTScrip™ mRNA-β gal (Cap 1, 30 nt-poly(A)) | Reporter Gene |
References